Second autologous stem cell transplantation as salvage therapy in patients with relapsed multiple myeloma: Improved outcomes in patients with longer disease free interval after first autologous stem cell transplantation

被引：2
|
作者：
Mikhael, J
Samiee, S
Stewart, AK
Chen, C
Trudel, S
Franke, N
Winter, A
Phillips, D
Reece, D
机构：
[1] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[2] Mayo Clin, Scottsdale, AZ USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2006年 / 12卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2005.11.359
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
335
引用
收藏
页码：117 / 117
页数：1
相关论文
共 50 条
  • [1] Second autologous stem cell transplant (ASCT) as salvage therapy in patients with relapsed multiple myeloma: Improved outcomes in patients with longer disease free interval after first ASCT
    Mikhael, Joseph R.
    Zadeh, Sahar
    Samiee, Sara
    Stewart, Keith
    Chen, Christine
    Trudel, Suzanne
    Kukreti, Vishal
    Franke, Norman
    Winter, Andrew
    Phillips, Drew
    Reece, Donna
    BLOOD, 2007, 110 (11) : 288A - 288A
  • [2] Outcome after second autologous stem cell transplantation as salvage therapy in patients with relapsed multiple myeloma.
    Mikhael, JR
    Samiee, S
    Stewart, AK
    Chen, C
    Trudel, S
    Franke, N
    Winter, A
    Chang, H
    Reece, DE
    BLOOD, 2004, 104 (11) : 270A - 270A
  • [3] Second Autologous Stem Cell Transplantation Is Effective Salvage Therapy for Relapsed Multiple Myeloma
    Chaidos, Aristeidis
    Giles, Chrissy
    Auner, Holger W.
    Bua, Marco
    Pavlu, Jiri
    Smith, Ellena
    Kanfer, Edward
    MacDonald, Donald
    Apperley, Jane F.
    Rahemtulla, Amin
    BLOOD, 2009, 114 (22) : 507 - 507
  • [4] SALVAGE AUTOLOGOUS STEM CELL TRANSPLANTATION FOR RELAPSED MULTIPLE MYELOMA
    Zannetti, B. A.
    Pezzi, A.
    Gamberi, B.
    Zamagni, E.
    Tosi, P.
    Rocchi, S.
    Cellini, C.
    Tacchetti, P.
    Ronconi, S.
    Pantani, L.
    Mancuso, K.
    Martello, M.
    Santacroce, B.
    Cavo, M.
    HAEMATOLOGICA, 2015, 100 : 510 - 510
  • [5] SALVAGE AUTOLOGOUS STEM CELL TRANSPLANTATION FOR RELAPSED MULTIPLE MYELOMA
    Zannetti, B. A.
    Pezzi, A.
    Gamberi, B.
    Zamagni, E.
    Tosi, P.
    Rocchi, S.
    Cellini, C.
    Tacchetti, P.
    Ronconi, S.
    Pantani, L.
    Mancuso, K.
    Rizzello, I.
    Martello, M.
    Testoni, N.
    Cavo, M.
    HAEMATOLOGICA, 2015, 100 : 32 - 32
  • [6] Outcomes of Salvage Second Autologous Stem Cell Transplantation for Relapsed/Refractory Multiple Myeloma in the Era of Modern Therapy
    Ayers, Emily Case
    Vogl, Dan T.
    Cohen, Adam D.
    Weiss, Brendan M.
    Cunningham, Kathleen
    Mangan, Patricia
    Erb, Colleen
    Shelly, Brenda
    Sanchez, Mary
    Kraus, Kelly
    Stadtmauer, Edward A.
    Garfall, Alfred L.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S212 - S213
  • [7] Impact of Maintenance Therapy after Salvage Autologous Stem Cell Transplantation in Relapsed Multiple Myeloma
    Kaedbey, Rayan
    Hay, Kevin
    Masih-Khan, Esther
    Kardjadj, Moustafa
    McCurdy, Arleigh
    Chu, Michael P.
    Jimenez-Zepeda, Victor H.
    Leblanc, Richard
    Song, Kevin
    Mian, Hira S.
    Louzada, Martha L.
    Sebag, Michael
    Reiman, Anthony
    White, Darrell J.
    Venner, Christopher P.
    Stakiw, Julie
    Kotb, Rami
    Aslam, Muhammad
    Bergstrom, Debra
    Gul, Engin
    Reece, Donna E.
    BLOOD, 2022, 140 : 10002 - 10004
  • [8] Matched-Pair Analysis Comparing Outcomes of Second Autologous Stem Cell Transplantation and Chemotherapy As a Salvage Therapy in Patients with Multiple Myeloma Who Relapsed After Front-Line Autologous Stem Cell Transplantation
    Yhim, Ho-Young
    Kim, Kihyun
    Kim, Jin Seok
    Kang, Hye Jin
    Kim, Jeong-A
    Min, Chang-Ki
    Bae, Sung Hwa
    Park, Eunkyung
    Yang, Deok-Hwan
    Suh, Cheolwon
    Kim, Min Kyoung
    Mun, Yeung-Chul
    Eom, Hyeon Seok
    Shin, Ho Jin
    Yoon, Hwi-Joong
    Kwon, Jung Hye
    Lee, Jae Hoon
    Kim, Yang Soo
    Yoon, Sung-Soo
    Kwak, Jae-Yong
    BLOOD, 2011, 118 (21) : 869 - 869
  • [9] EFFECTIVENESS AND TOXICITY OF SECOND AUTOLOGOUS STEM CELL TRANSPLANTATION AS SALVAGE THERAPY FOR RELAPSED OR PROGRESSIVE MULTIPLE MYELOMA
    El Fatmi, R.
    Bahri, M.
    Balloumi, D.
    Ben Abdeljelil, N.
    Torjemane, L.
    Lakhal, A.
    Ladeb, S.
    Ben Othman, T.
    HAEMATOLOGICA, 2016, 101 : 856 - 856
  • [10] Outcomes of Maintenance Therapy with Bortezomib after Autologous Stem Cell Transplantation for Patients with Multiple Myeloma
    Sivaraj, Dharshan
    Green, Michael M.
    Li, Zhiguo
    Sung, Anthony D.
    Sarantopoulos, Stefanie
    Kang, Yubin
    Long, Gwynn D.
    Horwitz, Mitchell E.
    Lopez, Richard D.
    Sullivan, Keith M.
    Rizzieri, David A.
    Chao, Nelson J.
    Gasparetto, Cristina
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (02) : 262 - 268
12345